Physician profile
Larisa Mararenko
NPI 1679662415
$7,461.08
in general payments reported to CMS, 2019-2025
40 companies · $943 in 2025
The $943 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $661 · 2021: $762 · 2022: $1,096 · 2023: $1,063 · 2024: $1,615 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,621.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $945.57 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $857.97 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $794.68 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $624.28 | 2019-2023 | Eliquis |
| Abbvie INC. | $603.97 | 2021-2025 | |
| Pfizer INC. | $519.20 | 2019-2025 | |
| Sk Life Science, INC. | $374.51 | 2022 | |
| Amgen INC. | $318.31 | 2019-2025 | Otezla, Repatha |
| Neurelis, INC. | $300.00 | 2023-2024 | Valtoco |
| Axsome Therapeutics, INC. | $241.22 | 2023-2024 | Auvelity |
| Merck Sharp & Dohme LLC | $220.94 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Teva Pharmaceuticals USA, INC. | $220.38 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $216.56 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $143.57 | 2019-2025 | Airsupra, Andexxa, Farxiga |
| Philips North America LLC | $118.55 | 2019-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larisa Mararenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.